Skip to main content

2024 Workshop Programme

Integrative & Personalised Medicine

Loading

GlucoMedix®: an all-natural phytotherapy for the prevention and treatment of the multiple comorbidities of Metabolic Syndrome

06 Jun 2024
Moore
Nutraceuticals

Recently, pharmacology, toxicity and human research were published in multiple peer-reviewed journals. GlucoMedix was compared to Glibenclamide, Enalapril and Atorvastatin producing similar pharmacological effects. Acute and subacute oral toxicity was performed with no toxicity, abnormal clinical chemistry or haematological effects observed. In a six patient case series, GlucoMedix reduced glucose levels and the need for pharmaceuticals in patients with type 2 diabetes. Although multiple prescription drugs are well known for the treatment of individual comorbidities of metabolic syndrome, no drug monotherapy concurrently treats all three comorbidities.

 

Speakers
Armin Schwarzbach, Managing Director & CEO ArminLabs

Hosted by:

Organised by Progressive Communications Ltd in association with The College of Medicine:

PC COM

 

With thanks to our Gold Sponsors:

  

 

With thanks to our Silver Sponsors:



                

With thanks to our Supporters:


 

Register

Lorem ipsum dolor sit amet, consectetuer adipiscing elit.

 

Exhibit

Lorem ipsum dolor sit amet, consectetuer adipiscing elit.

Conferences

Lorem ipsum dolor sit amet, consectetuer adipiscing elit.

Venue

Lorem ipsum dolor sit amet, consectetuer adipiscing elit.

IPMCongress

REGISTER TODAY FOR EARLY BIRD RATES

Join 2,000+ healthcare professionals from across the globe.

Space is limited so register today to secure your place.

REGISTER NOW >

We look forward to welcoming you to London